Oncolytics Biotech
Merle Crawford has been with Oncolytics Biotech Inc. for over 19 years, holding various positions related to regulatory and quality. Prior to joining the company, Merle completed education at the University of Manitoba and West Kildonan Collegiate in Winnipeg.
Oncolytics Biotech
Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called REOLYSIN® for the treatment of solid tumors and hematological malignancies.